| Literature DB >> 26095235 |
Shuo Jiao1, Ulrike Peters1, Sonja Berndt2, Stéphane Bézieau3, Hermann Brenner4,5, Peter T Campbell6, Andrew T Chan7, Jenny Chang-Claude8, Mathieu Lemire9, Polly A Newcomb1,10, John D Potter1,9,11, Martha L Slattery12, Michael O Woods13, Li Hsu1.
Abstract
Identification of gene-environment interaction (G × E) is important in understanding the etiology of complex diseases. Based on our previously developed Set Based gene EnviRonment InterAction test (SBERIA), in this paper we propose a powerful framework for enhanced set-based G × E testing (eSBERIA). The major challenge of signal aggregation within a set is how to tell signals from noise. eSBERIA tackles this challenge by adaptively aggregating the interaction signals within a set weighted by the strength of the marginal and correlation screening signals. eSBERIA then combines the screening-informed aggregate test with a variance component test to account for the residual signals. Additionally, we develop a case-only extension for eSBERIA (coSBERIA) and an existing set-based method, which boosts the power not only by exploiting the G-E independence assumption but also by avoiding the need to specify main effects for a large number of variants in the set. Through extensive simulation, we show that coSBERIA and eSBERIA are considerably more powerful than existing methods within the case-only and the case-control method categories across a wide range of scenarios. We conduct a genome-wide G × E search by applying our methods to Illumina HumanExome Beadchip data of 10,446 colorectal cancer cases and 10,191 controls and identify two novel interactions between nonsteroidal anti-inflammatory drugs (NSAIDs) and MINK1 and PTCHD3.Entities:
Keywords: G × E screening statistics; GWAS; eSBERUA; rare variants
Mesh:
Substances:
Year: 2015 PMID: 26095235 PMCID: PMC4675704 DOI: 10.1002/gepi.21908
Source DB: PubMed Journal: Genet Epidemiol ISSN: 0741-0395 Impact factor: 2.135